Savaria (TSX:SIS) Hit a Record Quarter. The Margin Story Is Real—The Valuation Question Is Too.

Savaria Q2 2026 results came in hot. Now the question is whether the factor stack that drove the rally is still intact or whether the stock has priced ahead of the runway.

Let's walk through the numbers.

Revenue: Record quarter, but the growth rate needs context.

Q2 revenue hit CAD $246 million, a record for the quarter, up 8.4% year-over-year. That's solid. But the 2030 target management laid out in April calls for approximately 12% annual growth to hit roughly $1.6 billion by end of 2030. The math on that target implies deceleration, not acceleration — to grow from roughly $990 million in fiscal 2025 to $1.6 billion by 2030, the compound rate works out to about 10.7%. Management's own roadmap does not support the 12% figure they stated every year through the horizon. The 8.4% run rate sits between the stated target and the arithmetic reality.

Both segments contributed. Accessibility, which accounts for roughly 78% of revenue, and Patient Care both grew. That's the right shape — no single segment is carrying the load. But 8.4% is not 12%, and if acquisitions are supposed to close that gap, the two deals to date (Baxter Residential Elevators in February and Western Elevator for $5.6 million) are rounding errors against a nearly $1 billion revenue base. Less than 1% acquisition contribution. This is an organic growth story with bolt-ons.

Margins: The A-grade factor.

Here's where the execution is genuinely good. Adjusted EBITDA margin (earnings before interest, taxes, depreciation, and amortization — a rough cash-earnings proxy) hit 21.1% in Q2, up 50 basis points from Q2 2025. Gross margin expanded to 39.6%, up 60 basis points. This follows a 190-basis-point margin jump in Q1, when adjusted EBITDA margin moved from 18.5% to 20.4%.

Operating income rose 34.1% to $35.8 million. Net earnings surged 54.4% to $25.2 million. The leverage effect is real — revenue grew 8.4% but net earnings grew 54.4%. That's what happens when margins expand while the fixed-cost base stays relatively flat.

The margin trajectory has directionality. Q1 2025 adjusted EBITDA margin was 18.5%. Q1 2026 was 20.4%. Q2 2026 is 21.1%. The improvement is continuing, not stalling. Management's "Savaria One" transformation program — which streamlined operations across 14 factories and roughly 2,550 employees — is showing up in the numbers.

Margin Grade: A. The trajectory is upward, the magnitude is real, and it's the factor doing the heavy lifting for earnings growth.

Earnings per share: The acceleration story.

Q2 EPS came in at $0.34, versus $0.29 in Q2 2025. That's a 17% increase on an 8.4% revenue increase. The adjusted EPS of $0.35 beat the consensus forecast of $0.33. Q1 EPS was $0.31 versus $0.17 a year ago. The year-over-year earnings growth is running well above revenue growth because of margin expansion, not revenue acceleration.

Full-year 2026 EPS estimate is $1.38, versus $0.95 for fiscal 2025. That's roughly 45% earnings growth expected. If the margin trajectory holds, the number has a path.

Earnings Growth Grade: A-. Strong growth, but the driver is margin expansion rather than top-line acceleration. If margins plateau, the earnings growth story slows with it.

Valuation: The C-grade factor.

Here's where the picture gets complicated. The stock trades at roughly 27.9 times trailing earnings. Market cap is approximately CAD $2.22 billion, enterprise value $2.39 billion. The share price has climbed from the low $20s a year ago to the high $30s, approaching 52-week highs. Analyst price targets cluster around $35 to $36.25.

At 28 times earnings, the market is pricing in sustained margin expansion and double-digit growth through 2030. There's no margin for error. If growth comes in at 8% rather than 12%, or if margins stabilize rather than continue expanding, the multiple compresses. The current price reflects a best-case scenario, not a baseline.

To put this in peer context, Savaria's accessibility market is fragmented. Direct public comparables are thin — Schindler Holding AG on the Swiss exchange is the closest large elevator name, but its business is heavily weighted toward commercial installations and maintenance contracts, not the residential stairlift and home elevator focus that drives Savaria's margins. Acorn Stairlifts and Bruno Independent Living are private. The fragmentation means Savaria is a consolidator, which should support margins, but it also means there's no clean peer multiple to anchor the valuation.

Valuation Grade: C. The stock is not cheap. It's priced for execution, and the execution window is narrow.

Safety: The B-grade factor.

Net debt was $178.7 million at the end of Q1, with a net debt-to-adjusted EBITDA ratio of 0.92, down from 1.03 at year-end 2025. Available funds total $324 million. The balance sheet is lean enough to fund acquisitions without stressing liquidity, but the leverage ratio has been declining because earnings are growing faster than debt. That's the right dynamic — the company is earning its way out of leverage rather than piling on more.

Safety Grade: B. Manageable leverage, improving trajectory, adequate cash. Not a stress point, not a strength either.

Momentum: The B-grade factor.

The stock hit 52-week highs in July 2026 and has climbed roughly 82% over the past year. Current price action near the highs suggests buyers are still active, but the technical picture is not a momentum rocket — it's a stock that has worked its way up through fundamentals, not a speculative tear. The 52-week range is $20.10 to $31.95, and the current level near $30.66 is well above the midpoint but not at the ceiling.

Momentum Grade: B. Positive trend, fundamental-driven, not overheated but not a cheap entry.

The factor stack summary:

Margin expansion (A) is driving earnings acceleration (A-), which is supporting the rally (B), on a manageable balance sheet (B), but the valuation (C) is already pricing in sustained execution.

The critical question is not whether Savaria delivered a good quarter. It is whether the margin trajectory can continue for the duration of the 2030 plan. If adjusted EBITDA margins hold above 20% and grow with revenue, the earnings compounding supports the current multiple. If margins plateau at 21%, the growth reverts to the revenue rate, and the 28x multiple becomes harder to defend on an 8-10% growth story.

Portfolio role:

Savaria belongs in a quality growth sleeve where the thesis is demographic tailwinds, margin expansion through consolidation, and operational improvement. It hedges against aging-population secular trends in North America. It is not a value play — the margin improvement is what's being priced. If you're already in the position, the factor stack doesn't scream sell, but the valuation grade is the reminder that the margin trajectory is the watch item. If margins stall, reduce. If they continue expanding, the stock earns its premium.

The stock is not cheap. The execution is good. The question is whether two things can be true at once, and for now, they are.